Skye Bioscience, Inc. - Special Call

Core Points - Skye Biosciences is conducting a conference call to discuss the results of its Phase IIa clinical trial [1] - The call includes forward-looking statements regarding the company's development activities and timelines, which are subject to risks and uncertainties [2] - The CEO of Skye Biosciences, Punit Dhillon, is leading the discussion [3]